Advertisement
Screener

ZYNERBA PHARMACEUTICALS, INC. Patents: Active

ZYNERBA PHARMACEUTICALS, INC. Active Patents

12 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2022-08-24: Application 17895008; Invention TREATMENT OF FRAGILE X SYNDROME WITH CANNABIDIOL; Applicant ZYNERBA PHARMACEUTICALS, INC.; Status Patented Case.
  • 2020-08-06: Application 16986622; Invention TREATMENT OF FRAGILE X SYNDROME WITH CANNABIDIOL; Applicant ZYNERBA PHARMACEUTICALS, INC.; Status Patented Case.
  • 2019-12-12: Application 16712066; Invention TREATMENT OF 22Q11.2 DELETION SYNDROME WITH CANNABIDIOL; Applicant ZYNERBA PHARMACEUTICALS, INC.; Status Patented Case.
  • 2019-10-07: Application 16594317; Invention TREATMENT OF FRAGILE X SYNDROME WITH CANNABIDIOL; Applicant ZYNERBA PHARMACEUTICALS, INC.; Status Patented Case.
FiledApplicationInventionApplicantStatusGrantedPatentPublished asInventor nameInventor countryExaminer
2022-08-2417895008TREATMENT OF FRAGILE X SYNDROME WITH CANNABIDIOLZYNERBA PHARMACEUTICALS, INC.Patented Case2023-10-1011779549US20230000790A1
Marcel Bonn-Miller
Nancy Tich
Donna Gutterman
John Messenheimer
Terri Sebree
United States
United States
United States
United States
United States
MELLER, MICHAEL V
2020-08-0616986622TREATMENT OF FRAGILE X SYNDROME WITH CANNABIDIOLZYNERBA PHARMACEUTICALS, INC.Patented Case2022-10-0411458110US20200360299A1
Marcel Bonn-Miller
Nancy Tich
Donna Gutterman
John Messenheimer
Terri Sebree
United States
United States
United States
United States
United States
MELLER, MICHAEL V
2019-12-1216712066TREATMENT OF 22Q11.2 DELETION SYNDROME WITH CANNABIDIOLZYNERBA PHARMACEUTICALS, INC.Patented Case2022-10-0411458109US20200188324A1
Terri Sebree
Donna Gutterman
United States
United States
WARD, PAUL V
2019-10-0716594317TREATMENT OF FRAGILE X SYNDROME WITH CANNABIDIOLZYNERBA PHARMACEUTICALS, INC.Patented Case2020-09-0110758497US20200030255A1
Marcel Bonn-Miller
Nancy Tich
Donna Gutterman
John Messenheimer
Terri Sebree
United States
United States
United States
United States
United States
MELLER, MICHAEL V
2019-05-1416411248TREATMENT OF AUTISM WITH CANNABIDIOLZYNERBA PHARMACEUTICALS, INC.Patented Case2020-02-2510568848US20190262280A1
Terri Sebree
Marcel Bonn-Miller
Donna Gutterman
United States
United States
United States
MELLER, MICHAEL V
2019-01-1616249732TREATMENT OF FRAGILE X SYNDROME WITH CANNABIDIOLZYNERBA PHARMACEUTICALS, INC.Patented Case2019-11-1210471022US20190167605A1
Marcel Bonn-Miller
Nancy Tich
Donna Gutterman
John Messenheimer
Terri Sebree
United States
United States
United States
United States
United States
MELLER, MICHAEL V
2018-12-1416220249TREATMENT OF AUTISM WITH CANNABIDIOLZYNERBA PHARMACEUTICALS, INC.Patented Case2019-06-1110314792US20190117588A1
Terri Sebree
Marcel Bonn-Miller
Donna Gutterman
United States
United States
United States
MELLER, MICHAEL V
2018-12-1316219285USE OF CANNABIDIOL PRODRUGS IN PHARMACEUTICAL COMPOSITIONSZynerba Pharmaceuticals, Inc.Patented Case2020-03-03RE47885
Audra Lynn Strinchcomb
Stan Lee Banks
Miroslaw Jerzy Golinski
Jeffrey Lynn Howard
Dana Carmel Hammel
United States
United States
United States
United States
United States
CAMPELL, BRUCE R
2018-09-2716144632TREATMENT OF FRAGILE X SYNDROME WITH CANNABIDIOLZYNERBA PHARMACEUTICALS, INC.Patented Case2019-02-2610213390
Marcel Bonn-Miller
Nancy Tich
Donna Gutterman
John Messenheimer
Terri Sebree
United States
United States
United States
United States
United States
MELLER, MICHAEL V
2016-12-0915374281PRODRUGS OF TETRAHYDROCANNABINOL, COMPOSITIONS COMPRISING PRODRUGS OF TETRAHYDROCANNABINOL AND METHODS OF USING THE SAMEZynerba Pharmaceuticals, Inc.Patented Case2018-05-019957246US20170088533A1
Audra Lynn Stinchcomb
Miroslaw Jerzy Golinski
Dana Carmel Hammell
Jeffery Lynn Howard
United States
United States
United States
United States
OH, TAYLOR V
2015-02-1114620016PRODRUGS OF TETRAHYDROCANNABINOL, COMPOSITIONS COMPRISING PRODRUGS OF TETRAHYDROCANNABINOL AND METHODS OF USING THE SAMEZynerba Pharmaceuticals, Inc.Patented Case2017-07-049695143US20150218121A1
Audra Lynn STINCHCOMB
Miroslaw Jerzy GOLINSKI
Dana Carmel HAMMELL
Jeffrey Lynn HOWARD
United States
United States
United States
United States
OH, TAYLOR V
2014-11-1214539824USE OF CANNABIDIOL PRODRUGS IN TOPICAL AND TRANSDERMAL ADMINISTRATION WITH MICRONEEDLESZYNERBA PHARMACEUTICALS, INC.Patented Case2017-01-039533942US20150197484A1
Audra Lynn STINCHCOMB
Stan Lee Banks
Miroslaw Jerzy Golinski
Jeffery Lynn Howard
Dana Carmel Hammell
United States
United States
United States
United States
United States
PACKARD, BENJAMIN J